Crosstalk with lung epithelial cells regulates Sfrp2-mediated latency in breast cancer dissemination

M Montagner, R Bhome, S Hooper, P Chakravarty… - Nature Cell …, 2020 - nature.com
M Montagner, R Bhome, S Hooper, P Chakravarty, X Qin, J Sufi, A Bhargava, CDH Ratcliffe…
Nature Cell Biology, 2020nature.com
The process of metastasis is complex. In breast cancer, there are frequently long time
intervals between cells leaving the primary tumour and growth of overt metastases,.
Reasons for disease indolence and subsequent transition back to aggressive growth
include interactions with myeloid and fibroblastic cells in the tumour microenvironment and
ongoing immune surveillance,–. However, the signals that cause actively growing cells to
enter an indolent state, thereby enabling them to survive for extended periods of time, are …
Abstract
The process of metastasis is complex. In breast cancer, there are frequently long time intervals between cells leaving the primary tumour and growth of overt metastases,. Reasons for disease indolence and subsequent transition back to aggressive growth include interactions with myeloid and fibroblastic cells in the tumour microenvironment and ongoing immune surveillance, –. However, the signals that cause actively growing cells to enter an indolent state, thereby enabling them to survive for extended periods of time, are not well understood. Here we reveal how the behaviour of indolent breast cancer cells in the lung is determined by their interactions with alveolar epithelial cells, in particular alveolar type 1 cells. This promotes the formation of fibronectin fibrils by indolent cells that drive integrin-dependent pro-survival signals. Combined in vivo RNA sequencing and drop-out screening identified secreted frizzled-related protein 2 (SFRP2) as a key mediator of this interaction. Sfrp2 is induced in breast cancer cells by signals from lung epithelial cells and promotes fibronectin fibril formation and survival, whereas blockade of Sfrp2 expression reduces the burden of indolent disease.
nature.com